Summit Trail Advisors LLC Purchases 2,433 Shares of Agilent Technologies, Inc. (NYSE:A)

Summit Trail Advisors LLC lifted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 135.6% during the 4th quarter, Holdings Channel reports. The firm owned 4,227 shares of the medical research company’s stock after purchasing an additional 2,433 shares during the quarter. Summit Trail Advisors LLC’s holdings in Agilent Technologies were worth $569,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. Livelsberger Financial Advisory acquired a new stake in shares of Agilent Technologies during the 3rd quarter worth about $28,000. CKW Financial Group boosted its holdings in shares of Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after acquiring an additional 100 shares during the period. Global X Japan Co. Ltd. grew its position in shares of Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 116 shares during the last quarter. Ashton Thomas Securities LLC bought a new position in shares of Agilent Technologies during the third quarter worth approximately $31,000. Finally, Fortitude Family Office LLC lifted its holdings in Agilent Technologies by 68.3% during the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after purchasing an additional 95 shares during the last quarter. 87.42% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on A shares. Citigroup boosted their target price on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a research report on Thursday, December 19th. Bank of America cut their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. JPMorgan Chase & Co. cut their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, November 26th. Finally, Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $135.00 to $145.00 in a report on Monday. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $144.38.

Agilent Technologies Trading Down 1.3 %

NYSE A opened at $141.77 on Wednesday. The company has a market cap of $40.45 billion, a price-to-earnings ratio of 32.07, a price-to-earnings-growth ratio of 4.00 and a beta of 1.07. Agilent Technologies, Inc. has a twelve month low of $124.16 and a twelve month high of $155.35. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57. The business’s fifty day moving average is $141.67 and its 200 day moving average is $139.43.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. The company had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. Agilent Technologies’s revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.38 earnings per share. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 5.56 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st were paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend was Tuesday, December 31st. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.40%.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. The trade was a 4.60 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.26% of the stock is owned by company insiders.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.